Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28.10.13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27.06.22 |
Chief Tech/Sci/R&D Officer | - | 01.11.19 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01.01.20 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19.09.07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13.09.22 |
Mark Vincent
BRD | Director/Board Member | 71 | 19.09.07 |
Director/Board Member | 74 | 15.12.14 | |
William Rice
CEO | Chief Executive Officer | 65 | 28.10.13 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07.04.11 |
Carol Ashe
BRD | Director/Board Member | 66 | 15.08.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 18 109 393 | 15 009 253 ( 82,88 %) | 0 | 82,88 % |
Unternehmenskontakt
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.com![Straße Aptose Biosciences](https://cdn.zonebourse.com/static/address/18469147.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+19.41% | 45.51 Mrd. | |
-8.62% | 38.52 Mrd. | |
+38.68% | 38.13 Mrd. | |
+26.95% | 30.74 Mrd. | |
-13.50% | 26.03 Mrd. | |
+10.74% | 25.92 Mrd. | |
+44.87% | 14.13 Mrd. | |
+34.36% | 12.73 Mrd. | |
-7.14% | 11.29 Mrd. |